Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cytosorbents Corporation (CTSO) stocks in Canada
Learn how to easily invest in Cytosorbents Corporation stocks.
Cytosorbents Corporation is a medical devices business based in the US. Cytosorbents Corporation stocks (CTSO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.68 – an increase of 4.39% over the previous week. Cytosorbents Corporation employs 195 staff and has a trailing 12-month revenue of around $44.3 million.
How to buy shares in Cytosorbents Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CTSO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Cytosorbents Corporation?
- Has coronavirus impacted Cytosorbents Corporation shares?
- Cytosorbents Corporation shares summary
- Compare share dealing platforms
- Is Cytosorbents Corporation stock a buy or sell?
- Cytosorbents Corporation performance over time
- Cytosorbents Corporation's financials
- How volatile are Cytosorbents Corporation shares?
- Does Cytosorbents Corporation pay a dividend?
- Have Cytosorbents Corporation shares ever split?
- Other common questions
Cytosorbents Corporation stock price (NASDAQ:CTSO)Use our graph to track the performance of CTSO stocks over time.
Cytosorbents Corporation shares at a glance
|Latest market close||$3.57|
|52-week range||$3.18 - $11.68|
|50-day moving average||$4.78|
|200-day moving average||$7.17|
|Wall St. target price||$12.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.37|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Cytosorbents Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cytosorbents Corporation price performance over time
|1 week (2022-01-19)||4.39%|
|1 month (2021-12-23)||-19.78%|
|3 months (2021-10-26)||-38.77%|
|6 months (2021-07-26)||-51.76%|
|1 year (2021-01-26)||-61.61%|
|2 years (2020-01-24)||-22.56%|
|3 years (2019-01-25)||7.22|
|5 years (2017-01-26)||5.65|
Cytosorbents Corporation financials
|Revenue TTM||$44.3 million|
|Gross profit TTM||$30 million|
|Return on assets TTM||-9.92%|
|Return on equity TTM||-21.12%|
|Market capitalisation||$148.7 million|
TTM: trailing 12 months
Cytosorbents Corporation share dividends
We're not expecting Cytosorbents Corporation to pay a dividend over the next 12 months.
Have Cytosorbents Corporation's shares ever split?
Cytosorbents Corporation's shares were split on a 1:25 basis on 4 December 2014. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cytosorbents Corporation shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Cytosorbents Corporation shares which in turn could have impacted Cytosorbents Corporation's share price.
Cytosorbents Corporation share price volatility
Over the last 12 months, Cytosorbents Corporation's shares have ranged in value from as little as $3.18 up to $11.684. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytosorbents Corporation's is 0.2544. This would suggest that Cytosorbents Corporation's shares are less volatile than average (for this exchange).
Cytosorbents Corporation overview
Cytosorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of post-operative complications of cardiopulmonary bypass surgery, and maintaining or improving the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, a device to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey. .
Stocks similar to Cytosorbents Corporation
Cytosorbents Corporation in the news
Cytosorbents : New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology - Form 8-K
CYTOSORBENTS CORP : Other Events (form 8-K)
New Publication Reports Significant Reductions in Perioperative Bleeding Complications Following Acute Aortic Dissection Surgery using CytoSorbents' Antithrombotic Drug Removal Technology
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.